Dr. Stephen Anthony Hightower , MD
Urology • Long Beach, CA
2888 Long Beach Blvd., Suite #340
Long Beach, CA 908061552
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on September 25, 2006; this date does not establish years in practice.
-
Published CMS data list 42,994 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 87798 — Detection test by nucleic acid for organism, amplified probe technique: 17,266 service units.
- 87481 — Detection test for candida species (yeast), amplified probe technique: 6,640 service units.
- 87801 — Detection test by nucleic acid for multiple organisms, amplified probe(s) technique: 3,985 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 29 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 3,344 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Tamsulosin Hcl — 898 prescription fills, including refills.
- Finasteride — 708 prescription fills, including refills.
- Alfuzosin Hcl Er (Alfuzosin Hcl) — 194 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 35 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Urology in California (2024, 779 clinicians with data). Median for this group: 1,340. Middle half: 505 to 3,668.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 3,994 in 2020 to 42,994 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
2888 Long Beach Blvd.
Suite #340
Long Beach, CA 908061552
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Coast Urological Medical Group, Inc.. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
University Of Vermont College Of Medicine
1993
What Public CMS Data Show
Urology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
692 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $1,861,007 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $1,736,009 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
7,952 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$287,303 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $671.83 across 24 records.
By nature of payment
- Food and Beverage: $585.67 across 21 records.
- Education: $86.16 across 3 records.
Reporting-company totals (3 largest of 14)
- UROGEN PHARMA, INC.: $194.66 across 6 records.
- Sumitomo Pharma America, Inc.: $80.61 across 4 records.
- Astellas Pharma US Inc: $68.00 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
33 years (graduated 1993)
CMS Doctors and Clinicians data list 1993 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Hightower has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Hightower as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Long Beach and California
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Urology in California (2024, 779 clinicians with data). Median for this group: 1,340. Middle half: 505 to 3,668.
Too few clinicians listed under Urology in Long Beach have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Urology in California (2024, 779 clinicians with data). Median for this group: $142,810. Middle half: $55,515 to $285,331.
Too few clinicians listed under Urology in Long Beach have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Urology in California (2024, 779 clinicians with data). Median for this group: $105,800. Middle half: $41,733 to $215,765.
Too few clinicians listed under Urology in Long Beach have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 90% of clinicians listed under Urology in California (2024, 1,070 clinicians with data). Median for this group: 911. Middle half: 244 to 1,758.
Too few clinicians listed under Urology in Long Beach have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 75% of clinicians listed under Urology in California (2024, 1,070 clinicians with data). Median for this group: $77,401. Middle half: $13,099 to $231,076.
Too few clinicians listed under Urology in Long Beach have Medicare Part D data for 2024 to compare.
10 active clinicians are listed under Urology with a practice address in Long Beach, CA (1,524 in California).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 976% from 3,994 in 2020 to 42,994 in 2024.
- 2020: 3,994
- 2021: 20,034
- 2022: 52,853
- 2023: 36,457
- 2024: 42,994
-
Medicare-allowed amount
Medicare-allowed amount increased 457% from $334,261 in 2020 to $1,861,007 in 2024.
- 2020: $334,261
- 2021: $555,140
- 2022: $1,325,429
- 2023: $1,730,437
- 2024: $1,861,007
-
Paid by Medicare
Paid by Medicare increased 586% from $252,964 in 2020 to $1,736,009 in 2024.
- 2020: $252,964
- 2021: $425,538
- 2022: $1,183,652
- 2023: $1,596,775
- 2024: $1,736,009
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 10% from 3,042 in 2020 to 3,344 in 2024.
- 2020: 3,042
- 2021: 3,026
- 2022: 3,357
- 2023: 3,000
- 2024: 3,344
-
30-day fills
30-day fills increased 13% from 7,044 in 2020 to 7,952 in 2024.
- 2020: 7,044
- 2021: 7,045
- 2022: 7,534
- 2023: 6,954
- 2024: 7,952
-
Part D drug cost
Part D drug cost varied from year to year: $265,214 in 2020 and $287,303 in 2024.
- 2020: $265,214
- 2021: $264,092
- 2022: $242,493
- 2023: $222,301
- 2024: $287,303
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $676.73 in 2021 to $671.83 in 2025.
- 2021: $676.73
- 2022: $636.12
- 2023: $687.21
- 2024: $486.08
- 2025: $671.83
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 24 records totaling $671.83.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Astellas Pharma US Inc |
Education
In-kind items and services
|
— | General | $68.00 |
| C. R. Bard, Inc. & Subsidiaries |
Food and Beverage
In-kind items and services
|
Bard Urinary Drainage Bag | General | $63.92 |
| UROGEN PHARMA, INC. |
Food and Beverage
In-kind items and services
|
JELMYTO | General | $46.29 |
| UROGEN PHARMA, INC. |
Food and Beverage
In-kind items and services
|
JELMYTO | General | $43.41 |
| UROGEN PHARMA, INC. |
Food and Beverage
In-kind items and services
|
JELMYTO | General | $43.40 |
| UROGEN PHARMA, INC. |
Food and Beverage
In-kind items and services
|
JELMYTO | General | $43.40 |
| Teleflex LLC |
Food and Beverage
In-kind items and services
|
UROLIFT | General | $28.65 |
| Procept Biorobotics Corporation |
Food and Beverage
In-kind items and services
|
AQUABEAM ROBOTIC SYSTEM | General | $28.24 |
| Boston Scientific Corporation |
Food and Beverage
In-kind items and services
|
Bulkamid | General | $25.72 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $25.49 |
| Endo USA, Inc. |
Food and Beverage
In-kind items and services
|
AVEED | General | $24.78 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $24.39 |
| TOLMAR, INC. |
Food and Beverage
In-kind items and services
|
ELIGARD | General | $22.56 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $22.33 |
| ACCORD HEALTHCARE, INC. |
Food and Beverage
In-kind items and services
|
Camcevi | General | $22.24 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $21.43 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $18.73 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $18.12 |
| Sagent Pharmaceuticals |
Food and Beverage
Cash or cash equivalent
|
Glydo | General | $17.07 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
LUPRON DEPOT | General | $16.52 |
| PROGENICS PHARMACEUTICALS, INC. |
Food and Beverage
In-kind items and services
|
PYLARIFY | General | $15.08 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
LUPRON DEPOT | General | $13.90 |
| UROGEN PHARMA, INC. |
Education
In-kind items and services
|
JELMYTO | General | $10.00 |
| UROGEN PHARMA, INC. |
Education
In-kind items and services
|
ZUSDURI | General | $8.16 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
87798
Detection test by nucleic acid for organism, amplified probe technique
|
17,266 | 508 | $40.00 | $34.39 |
|
87481
Detection test for candida species (yeast), amplified probe technique
|
6,640 | 508 | $40.00 | $34.39 |
|
87801
Detection test by nucleic acid for multiple organisms, amplified probe(s) technique
|
3,985 | 508 | $75.00 | $68.80 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
1,856 | 644 | $475.00 | $136.95 |
|
81015
Urinalysis using microscope
|
1,813 | 650 | $20.00 | $2.98 |
|
J1952
Leuprolide injectable, camcevi, 1 mg
|
1,345 | 19 | $235.00 | $56.76 |
|
87563
Detection of mycoplasma genitalium by dna or rna probe
|
1,337 | 508 | $38.00 | $34.39 |
|
87500
Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique
|
1,329 | 508 | $40.00 | $34.39 |
|
87640
Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique
|
1,329 | 508 | $40.00 | $34.39 |
|
87641
Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique
|
1,329 | 508 | $40.00 | $34.39 |
|
87651
Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique
|
1,329 | 508 | $40.00 | $34.39 |
|
87653
Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique
|
1,329 | 508 | $40.00 | $34.39 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
800 | 426 | $50.00 | $17.14 |
|
76775
Limited ultrasound scan behind abdominal cavity
|
628 | 324 | $275.00 | $66.36 |
|
96372
Injection of drug or substance under skin or into muscle
|
117 | 48 | $50.00 | $15.77 |
|
52000
Diagnostic exam of bladder and urethra using an endoscope
|
99 | 77 | $900.00 | $269.80 |
|
J0696
Injection, ceftriaxone sodium, per 250 mg
|
94 | 25 | $18.75 | $0.45 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
88 | 88 | $700.00 | $179.29 |
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
56 | 48 | $625.00 | $194.11 |
|
96402
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
|
45 | 21 | $85.00 | $40.08 |
|
76872
Ultrasound scan of pelvic region through rectum
|
30 | 29 | $725.00 | $158.13 |
|
55700
Biopsy of prostate gland
|
25 | 25 | $1025.00 | $264.40 |
|
76942
Ultrasonic guidance for needle placement
|
25 | 25 | $350.00 | $63.89 |
|
G0416
Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method
|
25 | 22 | $3060.00 | $181.52 |
|
J1580
Injection, garamycin, gentamicin, up to 80 mg
|
21 | 11 | $34.05 | $2.40 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Tamsulosin Hcl | Tamsulosin Hcl | 898 | 76,001 | $19,017.49 | 294 |
| Finasteride | Finasteride | 708 | 60,755 | $10,911.54 | 221 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 194 | 16,110 | $5,390.19 | 58 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 138 | 1,086 | $477.70 | 117 |
| Solifenacin Succinate | Solifenacin Succinate | 129 | 8,287 | $7,156.50 | 37 |
| Cefdinir | Cefdinir | 126 | 913 | $1,771.91 | 90 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 121 | 1,015 | $591.49 | 92 |
| Gemtesa | Vibegron | 109 | 6,010 | $94,431.43 | 29 |
| Trimethoprim | Trimethoprim | 107 | 7,953 | $3,939.97 | 39 |
| Myrbetriq | Mirabegron | 94 | 6,125 | $89,364.56 | 31 |
| Dutasteride | Dutasteride | 90 | 7,710 | $3,102.91 | 23 |
| Bicalutamide | Bicalutamide | 68 | 5,794 | $3,461.62 | 19 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 66 | 444 | $450.79 | 47 |
| Sildenafil Citrate | Sildenafil Citrate | 50 | 1,216 | $192.91 | 14 |
| Silodosin | Silodosin | 47 | 3,210 | $3,680.74 | 15 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 35 | 3,090 | $1,473.89 | 12 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 33 | 80 | $148.37 | 30 |
| Potassium Citrate Er | Potassium Citrate | 29 | 2,490 | $3,973.28 | 11 |
| Allopurinol | Allopurinol | 26 | 2,340 | $200.09 | — |
| Doxazosin Mesylate | Doxazosin Mesylate | 25 | 2,250 | $485.44 | — |
| Estradiol | Estradiol | 25 | 1,681 | $3,901.71 | 11 |
| Methenamine Hippurate | Methenamine Hippurate | 25 | 2,007 | $2,408.21 | 11 |
| Imipramine Hcl | Imipramine Hcl | 23 | 1,620 | $740.94 | — |
| Premarin | Estrogens, Conjugated | 20 | 660 | $8,860.58 | — |
| Levofloxacin | Levofloxacin | 19 | 164 | $74.12 | 13 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - UROLOGY
I20120316000653
CA
4981612280
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Coast Urological Medical Group, Inc.
3771 Katella Ave, Los Alamitos, CA 907203118
Phone: 5624300581
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Urology
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated September 25, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Urology Specialists in Long Beach
- Dr. Rathika Ramkumar, MD
- Dr. Joseph De Orio, MD
- Dr. Rena Malik, MD
- Dr. Albert Petrossian, MD
- Dr. William Kim, MD
- Dr. Greg Gin, MD
Mailing Address
2888 Long Beach Blvd., Suite #340
Long Beach, CA 908061552
Phone: 5625956891